comparemela.com

Latest Breaking News On - Second genome - Page 7 : comparemela.com

Second Genome to Host Virtual KOL Event to Discuss the Role of Mucosal Healing and PAI-1/2 in Inflammatory Bowel Disease on February 23

/PRNewswire/ Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers,.

United statesSilvio daneseRyan balfour sartorArena pharmaceuticalsUniversity vitaColitis foundation of americaDrug administrationUniversity of north carolina multidisciplinary centerGilead sciences incSecond genomeBalfour sartorDistinguished professorNorth carolina multidisciplinary centerChief medical advisorColitis foundationSan raffaele

Second Genome to Host Virtual KOL Event to Discuss the Role of Mucosal Healing and PAI-1/2 in Inflammatory Bowel Disease on February 23

/PRNewswire/ Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers,.

United statesSilvio daneseRyan balfour sartorArena pharmaceuticalsUniversity vitaColitis foundation of americaDrug administrationUniversity of north carolina multidisciplinary centerGilead sciences incSecond genomeBalfour sartorDistinguished professorNorth carolina multidisciplinary centerChief medical advisorColitis foundationSan raffaele

Second Genome Nominates Development Candidate Targeting PAI-1/2 for the Treatment of Inflammatory Bowel Disease (IBD)

/PRNewswire/ Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers,.

Joseph dal portoKarim dabbaghColitis organizationArena pharmaceuticalsDrug administrationGilead sciences incEuropean crohnChief executive officerSecond genomeChief science officerVirtual plenary hallMucosal healingGilead sciencesHealth care amp hospitalsMedical pharmaceuticalsOlls and research

Worldwide Genomic Biomarker Industry to 2027 - by Disease Indication, End-user and Region

/PRNewswire/ The "Global Genomic Biomarker Market 2021-2027" report has been added to ResearchAndMarkets.com s offering. The global genomics biomarker.

United statesUnited kingdomLaura woodAlmac groupPliant therapeutics incOrigene technologies incCelgene corpMerck kgaBanyan biomarkers incGenomic health incPfizer incKey company analysisEnzo life sciences incOffice hours callThermo fischer scientific incFoundation medicine inc

Second Genome Appoints Joseph Dal Porto, Ph D , as Chief Scientific Officer

/PRNewswire/ Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers from.

United statesDal portoJoseph dal portoKarim dabbaghJohns hopkins universityArena pharmaceuticalsNational jewish medical research centerUniversity of maryland school medicinePreclinical researchGilead sciences incChief scientificChief executive officerSecond genomeVice presidentEmerging scienceSite head

vimarsana © 2020. All Rights Reserved.